1. Home
  2. CBAN vs OCGN Comparison

CBAN vs OCGN Comparison

Compare CBAN & OCGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Colony Bankcorp Inc.

CBAN

Colony Bankcorp Inc.

HOLD

Current Price

$21.46

Market Cap

423.6M

Sector

Finance

ML Signal

HOLD

Logo Ocugen Inc.

OCGN

Ocugen Inc.

HOLD

Current Price

$1.37

Market Cap

474.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CBAN
OCGN
Founded
1975
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
423.6M
474.8M
IPO Year
1995
2014

Fundamental Metrics

Financial Performance
Metric
CBAN
OCGN
Price
$21.46
$1.37
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$9.75
AVG Volume (30 Days)
162.7K
4.1M
Earning Date
04-22-2026
05-05-2026
Dividend Yield
2.44%
N/A
EPS Growth
16.91
N/A
EPS
0.90
N/A
Revenue
N/A
N/A
Revenue This Year
$35.41
N/A
Revenue Next Year
$4.84
$1,718.38
P/E Ratio
$23.87
N/A
Revenue Growth
N/A
N/A
52 Week Low
$15.80
$1.00
52 Week High
$22.46
$2.73

Technical Indicators

Market Signals
Indicator
CBAN
OCGN
Relative Strength Index (RSI) 46.08 51.31
Support Level $19.20 $1.30
Resistance Level $22.43 $1.58
Average True Range (ATR) 0.43 0.07
MACD -0.14 0.01
Stochastic Oscillator 52.80 55.36

Price Performance

Historical Comparison
CBAN
OCGN

About CBAN Colony Bankcorp Inc.

Colony Bankcorp Inc is a bank holding company. The bank provides a broad range of banking services to its retail and commercial customers. Its product line includes loans to small and medium-sized businesses, residential and commercial construction and land development loans, commercial real estate loans, agri-business and production loans, residential mortgage loans, consumer loans, and a variety of demand, savings, and time deposit products. The company's segments include the Banking Division, Retail Mortgage Division and small business specialty lending divisions. It generates maximum revenue from the Banking Division.

About OCGN Ocugen Inc.

Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. The company's pipeline includes Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform, Inhaled Mucosal Vaccine Platform. The company is developing a modifier gene therapy platform designed to fulfill unmet medical needs related to retinal diseases, including inherited retinal diseases ("IRDs"), such as RP, LCA, Stargardt disease, and multifactorial diseases such as dAMD and Geographic Atrophy ("GA").

Share on Social Networks: